The new Cancer Inflammation Program has inspired two new projects in colon cancer that diverge from our previous focus on IL-7. One project involves IL-17A , IL-17 F and IL-25. These are T cell cytokines that are produced by cells that strongly promote the intestinal inflammation that leads to colon cancer. It has not been determined where IL-17 and 25 are produced during this inflammatory response. We have developed knockin reporter mice for the two IL-17 genes using two colors and for IL-25. This will enable us to visualize cells producing these critical inflammatory cytokines during bowel inflammation leading to colon cancer. A second project aims to inhibit the bowel inflammation leading to colon cancer. IL-27 and IL-35 are suppressive cytokines that we have cloned into the food bacterium, Lactococcus lactis. These engineered bacteria will be given orally to mice to try to inhibit bowel inflammation leading to colon cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Investigator-Initiated Intramural Research Projects (ZIA)
Project #
1ZIABC011150-01
Application #
7966115
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
2009
Total Cost
$419,748
Indirect Cost
Name
National Cancer Institute Division of Basic Sciences
Department
Type
DUNS #
City
State
Country
Zip Code
Aiello, Francesca B; Guszczynski, Tad; Li, Wenqing et al. (2018) IL-7-induced phosphorylation of the adaptor Crk-like and other targets. Cell Signal 47:131-141
Senkevitch, Emilee; Li, Wenqing; Hixon, Julie A et al. (2018) Inhibiting Janus Kinase 1 and BCL-2 to treat T cell acute lymphoblastic leukemia with IL7-R? mutations. Oncotarget 9:22605-22617
Francois, Bruno; Jeannet, Robin; Daix, Thomas et al. (2018) Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial. JCI Insight 3:
Andrews, Caroline; McLean, Mairi H; Durum, Scott K (2018) Cytokine Tuning of Intestinal Epithelial Function. Front Immunol 9:1270
Cramer, Sarah D; Hixon, Julie A; Andrews, Caroline et al. (2018) Mutant IL-7R? and mutant NRas are sufficient to induce murine T cell acute lymphoblastic leukemia. Leukemia 32:1795-1882
Yoshimura, Teizo; McLean, Mairi H; Dzutsev, Amiran K et al. (2018) The Antimicrobial Peptide CRAMP Is Essential for Colon Homeostasis by Maintaining Microbiota Balance. J Immunol 200:2174-2185
Rodriguez-Palacios, Alexander; Harding, Andrew; Menghini, Paola et al. (2018) The Artificial Sweetener Splenda Promotes Gut Proteobacteria, Dysbiosis, and Myeloperoxidase Reactivity in Crohn's Disease-Like Ileitis. Inflamm Bowel Dis 24:1005-1020
Porter, Ross John; Andrews, Caroline; Brice, Daniel Paul et al. (2018) Can We Target Endogenous Anti-inflammatory Responses as a Therapeutic Strategy for Inflammatory Bowel Disease? Inflamm Bowel Dis :
Shen, Wei; Li, Wenqing; Hixon, Julie A et al. (2017) Visualization of IL-22-expressing Lymphocytes Using Reporter Mice. J Vis Exp :
McLean, Mairi H; Andrews, Caroline; Hanson, Miranda L et al. (2017) Interleukin-27 Is a Potential Rescue Therapy for Acute Severe Colitis Through Interleukin-10-Dependent, T-Cell-Independent Attenuation of Colonic Mucosal Innate Immune Responses. Inflamm Bowel Dis 23:1983-1995

Showing the most recent 10 out of 21 publications